By Michael Grass, Ph.D., and David Vodak, Ph.D., Bend Bioscience The pharmaceutical industry faces persistent challenges in formulating poorly water-soluble drugs, which make up the majority of new chemical entities (NCEs). Amorphous solid dispersions (ASDs), particularly those prepared by spray drying (SDDs), effectively enhance solubility and dissolution.